GenScript ProBio Establishes Korean Legal Entity and Further Strengthens Cooperation in South Korea and APAC Region

13 May 2022 | Friday | News

On the May 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO company from GenScript Biotech Corporation, today announced the opening of a legal entity in South Korea at the BIO KOREA 2022 International Convention. BIO KOREA 2022 International Convention is the biggest bio-health convention in Asia.
Dr.Brian Min, CEO of GenScript ProBio, given speech at conference

Dr.Brian Min, CEO of GenScript ProBio, given speech at conference

During the BIO KOREA 2022, Dr. Brian H. Min, CEO of GenScript ProBio, introduced the development history of GenScript ProBio to the participants and officially announced that GenScript ProBio established a legal entity in South Korea.

Since the establishment of GenScript Biotech Corporation and GenScript ProBio, they have been actively exploring in the field of bioprocessing and manufacturing, facilitating bio manufacturing excellence at enhanced speed, reduced cost, and superior quality to support the innovation plans of customers in South KoreaAsia Pacific and around the world, and GenScript ProBio has cooperated with several customers from Korea. With outstanding technical strength and high-quality CDMO services, GenScript Biotech Corporation received the "Best Contract Development and Manufacturing Organization Award" at the Asia Pacific Bioprocessing Excellence Awards 2022. This marks the third consecutive year of GenScript bagging the same award in the Asia Pacific region. The award also followed GenScript's recognition at the Korea Bioprocessing Excellence Awards in 2021 for the 'Best Contract Development and Manufacturing Organization Award'.

"We are very pleased to announce the establishment of a legal entity called 'Genscript Probio Biotech Korea Ltd.'  at the BIO KOREA conference", said Dr. Brian Min, CEO of GenScript ProBio. "South Korea is one of the most dynamic innovation centers of the biotech industry in the Asia-Pacific region. We are looking forward to working with scientists and partners in South Korea, utilizing GenScript ProBio's one-stop CDMO service platform from drug discovery to commercialization in cell and gene therapy, vaccine, biologics discovery and antibody protein drug, and are committed to improving human life and health."


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in